Remedium Lifecare Ltd., a fast-emerging player in the pharmaceutical supply chain and specialty chemicals sector, has announced the appointment of Mr. Vignesh Laxman Gawde as Whole-Time Director and Mr. Rambhajan Vishwakarma as Independent Director. The addition of these seasoned professionals to the Board marks a significant step in taking the company to its next level of growth, innovation, and governance excellence. Commenting on the development, Mr. Adarsh Munjal, Managing Director, Remedium Lifecare Ltd., said, “These appointments come at a pivotal time as Remedium Lifecare accelerates its growth momentum. Mr. Gawde’s deep technical expertise in pharmaceutical field and Mr. Vishwakarma’s vast experience in the financial sector will bring a strong strategic balance to our leadership team. Together, they will play a key role in guiding the company toward operational excellence, innovation-driven growth, and enhanced shareholder value.” Mr. Vignesh Laxman Gawde brings over 14 years of experience in pharmaceutical research and analytical development, having worked with leading organizations such as Ajanta Pharma Ltd., Inventia Healthcare Pvt. Ltd., and Elder Pharmaceuticals Ltd. An M.Sc. in Physical Chemistry from the Institute of Science, Mumbai University, Mr. Gawde has strong expertise in analytical method validation, stability studies, and quality systems. As Whole-Time Director, he will focus on strengthening R&D, quality assurance, and innovation, driving Remedium Lifecare’s expansion across key therapeutic areas, including anti-infectives, cardiovascular, and CNS treatments. Mr. Rambhajan Vishwakarma brings over 15 years of experience in the banking and financial services industry, having worked with HDFC Bank, ICICI Bank, HDB Financial Services, Capri Global Capital Ltd., and Andromeda Sales & Distribution Pvt. Ltd.
His proven expertise in retail finance, business development, and strategic sales management will support Remedium Lifecare’s financial prudence and growth strategy. As Independent Director, he will contribute to strengthening corporate govemance, transparency, and financial oversight, ensuring the company’s continued alignment with best industry practices. The appointments of Mr. Vignesh Laxman and Mr. Rambhajan Vishwakarma brings commitment to building a strong, future-ready leadership structure. Their combined experience across pharmaceutical Sector and financial management is expected to propel the company into its next phase of expansion enhancing R&D capabilities, strengthening operational efficiencies, and deepening market presence across domestic and global geographies. Remedium Lifecare Ltd. is an emerging pharmaceutical and specialty chemicals company focused on developing and distributing advanced healthcare solutions. With a growing emphasis on R&D, CDMO services, and international expansion, the company is committed to delivering innovation-driven, high-quality, and affordable healthcare products. About Remedium Lifecare Ltd.: Founded in 1988, Remedium Lifecare Ltd. is a BSE-listed pharmaceutical company engaged in the trading and distribution of raw material as a supply chain management for the pharmaceutical industry with an emphasis on quality, compliance, and global reach, the company continues to expand its presence while playing a pivotal role in India’s pharmaceutical ecosystem
India’s small business owners honored at the Grand Premiere of Muthoot FinCorp SPARK Awards 
GREW Solar Wins ‘Solar Energy Manufacturer of the Year 2025’ at the Go Global Awards 
India’s pharma exports nearing $30 billion, with CRDMOs and GCCs driving next phase of innovation: EY-Parthenon–OPPI report 
360 ONE Asset appoints Pritam Doshi as CIO – Renewable Energy 
APM Terminals Pipavav Strengthens Rural Healthcare with 8,000+ Eye Care Beneficiaries 
CDSL kicks off Ideathon inviting students to reimagine investor education and engagement for Atmanirbharta